7. Can Recombinant Zoster Vaccine Administration Decrease the Use of Herpes Zoster-related Pain Medication Across Randomized Controlled Studies?

BACKGROUND: Older and immunocompromised adults are at increased risk for herpes zoster (HZ) and often experience persistent, severe HZ-related pain, impacting their quality of life and activities of daily living. High vaccine efficacy (VE) of the adjuvanted recombinant zoster vaccine (RZV) in preven...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Kim, Joon Hyung, Johnson, Robert, Kovac, Martina, Cunningham, Anthony L, Emmadi, Srikanth, Sullivan, Keith, Dagnew, Alemnew F, Curran, Desmond, Schuind, Anne
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Oral Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7776046/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa417.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados